Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.

Scientific reports·2026
Same author

Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.

Scientific reports·2026
Same author

Architecture and function of holocentric CENP-A-independent inner kinetochores.

Science advances·2026
Same author

Targeting oncogenic TβRI signaling inhibits androgen-independent prostate cancer growth and metastasis.

Signal transduction and targeted therapy·2026
Same author

Connected care: A telehealth and patient-reported outcome measure-based model for post-arthroplasty follow-up in a public hospital system.

Journal of telemedicine and telecare·2026
Same author

Slow RNAPII elongation enhances naive pluripotency rewiring while maintaining high replication fork speed.

Science advances·2026

Related Experiment Video

Updated: May 10, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Altered dNTP pools accelerate tumor formation in mice.

Phong Tran1, Pradeep Mishra1, Leonard G Williams2,3

  • 1Department of Medical Biochemistry and Biophysics, Umeå University, Linnaeus väg 6, Umeå, SE 90736, Sweden.

Nucleic Acids Research
|October 3, 2024
PubMed
Summary

Altering deoxyribonucleoside triphosphate (dNTP) pools via ribonucleotide reductase mutations accelerates tumor development in mice. This study links dNTP pool changes to cancer progression and identifies distinct mutational signatures.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

Related Experiment Videos

Last Updated: May 10, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
05:06

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector

Published on: February 2, 2021

Area of Science:

  • Biochemistry
  • Genetics
  • Oncology

Background:

  • Alterations in deoxyribonucleoside triphosphate (dNTP) pools are associated with increased mutation rates and genome instability.
  • The specific role of dNTP pool changes in mammalian tumor development is not well understood.

Purpose of the Study:

  • To investigate the impact of altered dNTP pools on tumor development in mammals.
  • To establish a mouse model mimicking impaired dNTP synthesis.

Main Methods:

  • Created a mouse model with a point mutation (RRM1-Y285A) in ribonucleotide reductase.
  • Analyzed dNTP pool alterations across organs in heterozygous Rrm1+/Y285A mice.
  • Performed mutational spectrum analysis on tumors from these mice.

Main Results:

  • The RRM1-Y285A mutation reduced ribonucleotide reductase activity, decreasing deoxyadenosine triphosphate (dATP) and deoxyguanosine triphosphate (dGTP) synthesis.
  • Heterozygous mice showed altered dNTP pools, reduced lifespan, and earlier tumor onset compared to wild-type controls.
  • Tumor mutational analysis revealed signatures similar to human cancers with related mutations.

Conclusions:

  • Mutations in dNTP metabolism enzymes can drive cancer development.
  • Altered dNTP pools contribute to genome instability and tumorigenesis in mammals.
  • The RRM1-Y285A mouse model provides insights into cancer mechanisms driven by dNTP pool imbalances.